Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:36 2024-05-02 am EDT			5-day change	1st Jan Change
16.36 ^SEK	-6.99%		-12.79%	-40.72%

Apr. 30	Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory	MT
Apr. 11	Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System	CI

BioStock: CLS makes progress in prostate cancer in Europe and the US

April 12, 2024 at 03:15 am EDT

Clinical Laserthermia Systems has treated its first prostate cancer patients in Italy and secured additional orders and agreements in the US. In addition, the company has presented initial clinical data from the study at Radboud University Medical Center in the Netherlands.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/04/cls-makes-progress-in-prostate-cancer-in-europe-and-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/cls/r/biostock-cls-makes-progress-in-prostate-cancer-in-europe-and-the-us,c3960725

Latest news about Clinical Laserthermia Systems AB

Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory	Apr. 30	MT
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System	Apr. 11	CI
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories	Apr. 09	CI
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy	Apr. 02	CI
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System	Mar. 28	CI
Clinical Laserthermia Systems Names Interim CFO	Mar. 22	MT
Clinical Laserthermia Systems AB Announces CFO Changes	Mar. 22	CI
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System	Mar. 11	CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 23	CI
Clinical Laserthermia Systems Gains Underwriting Commitments for Warrant Series Exercise	Feb. 02	MT
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators	Jan. 30	MT
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044	Jan. 30	CI
Clinical Laserthermia Systems Prices Warrants; Stock Falls	Jan. 22	MT
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA	Jan. 17	CI
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore	Jan. 15	MT
Clinical Laserthermia Systems AB Receives Market Approval for Its TRANBERG Portfolio by HSA in Singapore and Initiates the Process of Commercialization in the Region	Jan. 15	CI
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise	Jan. 09	MT
Clinical Laserthermia Systems Receives SEK 8.1 Million Order from Clearpoint Neuro	Jan. 09	CI
Clinical Laserthermia Systems AB Announces Members of the Nomination Committee Appointments	Dec. 28	CI
Clinical Laserthermia Systems AB Announces Executive Changes	Dec. 19	CI
Clinical Laserthermia Reports First Prostate Cancer Patient Treatment Using Tranberg Therapy	Dec. 05	MT
Clinical Laserthermia Systems AB Announces First Patient was Safely Treated with CLS TRANBERG® Thermal Therapy system for laser ablation of Prostate Cancer	Dec. 05	CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Clinical Laserthermia Partners with Avanco Advanced Medical Solutions for Tranberg Sale in Portugal	Nov. 16	MT

Chart Clinical Laserthermia Systems AB

Duration

Period

More charts

Company Profile

Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-16 - Q1 2024 Earnings Release

More about the company